{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:58Z","timestamp":1787071018556,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Parameningeal rhabdomyosarcomas (PM RMSs) are rarely seen childhood tumors. Their treatment might be challenging and prognosis is poor compared to other head and neck RMS. Here we report a PM RMS presenting with leptomeningeal seeding metastasis a year after diagnosis. A five-year-old girl presented with an enlarging mass protruding from the right ear and right facial paralysis. Magnetic resonance imaging (MRI) revealed a large mass extending from right external auditory canal to the temporal lobe, pterygoid fossa and nasopharynx with an intracranial component indenting the right temporal lobe and extending into the right cavernous sinus. Trucut biopsy revealed embryonal rhabdomyosarcoma. Cerebrospinal fluid (CSF) cytology was negative for malignant cells. Chemotherapy was started since it was found unresectable. At second week of chemotherapy, radiotherapy was applied to primary tumor location with intensity-modulated radiation therapy (IMRT) technique in 1.8 Gy fractions to total dose of 50.4 Gy. At week 27, MRI showed significant response. At week 36, the patient presented with vomiting and tendency to sleep. MRI was found to be compatible with meningitis and antibacterial therapy was started. At week 39, chemotherapy was stopped. But MRI performed one month later revealed linear contrast enhancements around the spinal cord compatible with leptomeningeal metastases. Chemotherapy and craniospinal irradiation were applied. But the patient did not improve and received palliative treatment. Six months after the completion of radiotherapy the patient died. Treatment of parameningeal rhabdomyosarcomas require multidisciplinary approach including surgery, radiotherapy, and chemotherapy. Prognosis is poor for patients with leptomeningeal spread.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1491_20","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T02:20:46Z","timestamp":1665714046000},"page":"1823-1826","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Challenging treatment of parameningeal rhabdomyosarcoma with leptomeningeal metastasis"],"prefix":"10.4103","volume":"18","author":[{"given":"Rahmi At\u0131l","family":"Aksoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Karaali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek Gamze","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130nan\u00e7 Elif","family":"G\u00fcrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Akba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine Gen\u00e7","family":"\u00d6zay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-62-20241021","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F","article-title":"Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type","volume":"75","author":"Gurney","year":"1995","journal-title":"Cancer"},{"key":"R2-62-20241021","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jcms.2017.03.005","article-title":"Rhabdomyosarcoma of the maxillofacial region in children and adolescents: Report of 9 cases and literature review","volume":"45","author":"Iatrou","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"R3-62-20241021","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2004.08.005","article-title":"Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma","volume":"61","author":"Wolden","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-62-20241021","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1097-0142(19881001)62:7<1257::AID-CNCR2820620703>3.0.CO;2-K","article-title":"Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. A report from the Intergroup Rhabdomyosarcoma Study (IRS)-I","volume":"62","author":"Raney","year":"1988","journal-title":"Cancer"},{"key":"R5-62-20241021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mpo.1259","article-title":"Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997","volume":"38","author":"Raney","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"R6-62-20241021","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ijrobp.2015.08.040","article-title":"Local control for \u0131ntermediate-risk rhabdomyosarcoma: Results from D9803 according to histology, group, site, and size: A report from the children's oncology group","volume":"93","author":"Wolden","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-62-20241021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/annonc\/mdt426","article-title":"Parameningeal rhabdomyosarcoma in pediatric age: Results of a pooled analysis from North American and European cooperative groups","volume":"25","author":"Merks","year":"2014","journal-title":"Ann Oncol"},{"key":"R8-62-20241021","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MPH.0000000000001188","article-title":"Excessive treatment failures in patients with parameningeal rhabdomyosarcoma with reduced-dose cyclophosphamide and delayed radiotherapy","volume":"40","author":"Lucas","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"R9-62-20241021","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0959-8049(98)00080-X","article-title":"Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine\/doxorubicin\/cyclophosphamide and etoposide\/ifosfamide","volume":"34","author":"Arndt","year":"1998","journal-title":"Eur J Cancer"},{"key":"R11-62-20241021","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0360-3016(01)01709-6","article-title":"Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--A report from the IRSG","volume":"51","author":"Donaldson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-62-20241021","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1097-0142(19870101)59:1<147::AID-CNCR2820590129>3.0.CO;2-8","article-title":"Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma study","volume":"59","author":"Raney","year":"1987","journal-title":"Cancer"},{"key":"R14-62-20241021","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1200\/JCO.1990.8.11.1854","article-title":"Questionable role of CNS radioprophylaxis in the therapeutic management of childhood rhabdomyosarcoma with meningeal extension","volume":"8","author":"Gasparini","year":"1990","journal-title":"J Clin Oncol"},{"key":"R15-62-20241021","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.ijrobp.2012.08.019","article-title":"Parameningeal rhabdomyosarcoma: Outcomes and opportunities","volume":"85","author":"Yang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-62-20241021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/CMAR.S185414","article-title":"Helical tomotherapy in patients with leptomeningeal metastases","volume":"11","author":"Schiopu","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R17-62-20241021","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: Current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget"},{"key":"R18-62-20241021","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00381-016-3318-5","article-title":"An aggressive parameningeal rhabdomyosarcoma with multiple spinal cord metastases: A case report and review of the literature","volume":"33","author":"Yavas","year":"2017","journal-title":"Childs Nerv Syst"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1491_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:24Z","timestamp":1787067624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1491_20"}},"subtitle":["Case report and review of literature"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1491_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}